K
Kailin Yang
Researcher at Capital Medical University
Publications - 49
Citations - 683
Kailin Yang is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 27 publications receiving 338 citations. Previous affiliations of Kailin Yang include Hunan University.
Papers
More filters
Journal ArticleDOI
Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach.
Liuting Zeng,Kailin Yang +1 more
TL;DR: This work successfully predict, illuminate and confirm the molecular synergy of YHD for HER2-positive breast cancer and found the potential Her2- positive breast cancer associated targets, cluster, biological processes and pathways.
Journal ArticleDOI
Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis
TL;DR: Omega-3 fatty acid may be recommended for the treatment of PCOS with insulin resistance as well as high TC (especially LDL-C) and TG and increase adiponectin level based on current evidence.
Journal ArticleDOI
A Network Pharmacology Approach to Explore the Pharmacological Mechanism of Xiaoyao Powder on Anovulatory Infertility.
TL;DR: Some signal pathways of XYP acting on infertility are found for the first time and some biological processes can also be identified as XYP's effects on anovulatory infertility.
Journal ArticleDOI
Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis
TL;DR: Based on current evidence, Boswellia and its extract may be an effective and safe treatment option for patient with OA, and the recommended duration of treatment is at least 4 weeks.
Journal ArticleDOI
Uncovering the Pharmacological Mechanism of Astragalus Salvia Compound on Pregnancy-Induced Hypertension Syndrome by a Network Pharmacology Approach
TL;DR: It is thought that Astragalus Salvia Salvia compound may directly regulate several biological processes and their genes in “endothelial cell activation and injury” and “placental or trophoblast cell ischemia” models to treat PIH.